Institute of Pathology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial (2024) Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, et al. Journal article Discrimination between Inflammatory and Fibrotic Activity in Crohn's Disease-Associated Ileal-Colonic Anastomotic Strictures by Combined Ga-68-FAPI-46 and F-18-FDG-PET/CT Imaging (2024) Beck M, Kuwert T, Atzinger A, Gerner M, Hartmann A, Saake M, Uder M, et al. Journal article Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. (2023) Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev E, et al. Journal article Explainable convolutional neural networks for assessing head and neck cancer histopathology (2023) Dörrich M, Hecht M, Fietkau R, Hartmann A, Iro H, Gostian AO, Eckstein M, Kist A Journal article Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) (2023) Breyer J, Eckstein M, Sikic D, Wezel F, Roghmann F, Brehmer M, Wirtz RM, et al. Journal article Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach (2023) Henderson RH, French D, Stewart E, Smart D, Idica A, Redmond S, Eckstein M, et al. Journal article ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway (2023) Yang H, Hübner K, Hampel C, Erlenbach-Wünsch K, Selvamani SB, Shukla V, Geppert CI, et al. Journal article Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target (2023) Groenewoud A, Yin J, Gelmi MC, Alsafadi S, Nemati F, Decaudin D, Roman-Roman S, et al. Journal article Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma (2023) Erlmeier M, Mikuteit M, Zschaebitz S, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F Journal article Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression (Scientific Reports, (2023), 13, 1, (73), 10.1038/s41598-022-26579-z) (2023) Saponaro M, Flottmann S, Eckstein M, Hommerding O, Klümper N, Corvino D, Hosni S, et al. Journal article, Erratum